Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutationsC. Mircea S. Tesileanu, Pim J. French, Paul M. Clément et al.|Acta Neuropathologica|2021Cited by 60
Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation StatusSanne Venneker, Judith V.M.G. Bovée|Cancers|2019Cited by 31